INTELLIGENT BIO SOLUTIONS INC. Current Liabilities
INTELLIGENT BIO SOLUTIONS INC. (INBS) had Current Liabilities of $4.93 million as of 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-19
- 2026-06-30: Liabilities, Current $4.93M.
- 2026-03-31: Liabilities, Current $4.61M.
- 2025-12-31: Liabilities, Current $5.13M.
- 2025-09-30: Liabilities, Current $5.06M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $4.93M 10-K · filed 2026-08-19 |
| 2026-03-31 | $4.61M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $5.13M 10-Q · filed 2026-02-12 |
| 2025-09-30 | $5.06M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $5.35M 10-K · filed 2026-08-19 |
| 2025-03-31 | $4.56M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $4.40M 10-Q · filed 2025-02-13 |
| 2024-09-30 | $5.68M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $5.45M 10-K · filed 2025-08-15 |
| 2024-03-31 | $5.71M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $5.18M 10-Q · filed 2024-02-09 |
| 2023-09-30 | $6.85M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $5.88M 10-K · filed 2024-09-18 |
| 2023-03-31 | $3.54M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $4.81M 10-Q · filed 2023-02-14 |
| 2022-09-30 | $2.36M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $4.66M 10-K · filed 2023-08-23 |
| 2022-03-31 | $4.43M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $4.01M 10-Q · filed 2022-02-11 |
| 2021-09-30 | $2.83M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $3.68M 10-K · filed 2022-09-22 |
| 2021-03-31 | $1.56M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $1.17M 10-Q · filed 2021-02-12 |
| 2020-06-30 | $7.69M 10-K · filed 2021-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |